Class III Director (2007) Compensation Committee (Chair) Governance and Nominating Committee
Mr. Fitzsimmons has served on the company's board since 1996 and as chairman of the board since 2005. He has been chairman and chief executive officer of Archus Orthopedics, Inc., a spinal implant company, since 2000. From 2000 to 2003, he was founder and managing director of Scout Medical LLC, a medical device incubator, and from 1997 to 1999, he was senior vice president and general manager of the Cardiac and Vascular Surgery Group of Guidant Corporation, a medical device company. Mr. Fitzsimmons serves on the board of several privately held medical device companies. He holds both a B.S. degree in Biology-Premedical and an M.B.A. degree from Seattle University.
Michael J. Coyle
Class I Director (2008) Compensation Committee Governance and Nominating Committee (Chair)
Michael J. Coyle was appointed to the Board of Directors in July 2005. From 2001 through December 31, 2007, he was president of the Cardiac Rhythm Management Division of St. Jude Medical, Inc., a medical device company specializing in the development and manufacturing of cardiovascular devices. Mr. Coyle joined St. Jude Medical as director of Business Development in 1994 and was appointed president of the Daig Division, a specialty catheter business, in 1997. Previously, Mr. Coyle spent nine years in business and technical management positions in the medical device and pharmaceutical divisions of Eli Lilly & Company. He holds a B.S. in Chemical Engineering from Case Western Reserve University and an M.B.A. from the Wharton School of the University of Pennsylvania.
Brian E. Farley
Class III Director (2007) President and Chief Executive Officer
Mr. Farley joined the company as its general manager and first employee in 1995, and has served on the board and as president and chief executive officer since 1996. Before joining the company, he held various management and executive positions in research and development, clinical research and business development at Guidant Corporation, a medical device company, and in the medical device division of Eli Lilly and Company, a diversified healthcare company. Mr. Farley holds both a B.S. degree in Engineering, with an emphasis in Biomedical Engineering, and an M.S. degree in Electrical Engineering from Purdue University.
Kathleen D. LaPorte
Class II Director (2006) Compensation Committee
Ms. LaPorte has served on the company's board since 1997. Since 2005, she has been a managing director of New Leaf Venture (NLV) Partners, a life science venture capital firm spun out of the Sprout Group, where she has been a general partner since 1994. She currently serves on the boards of ISTA Pharmaceuticals, Inc., a biopharmaceutical company, and several privately held companies. Ms. LaPorte holds a B.S. degree in Biology from Yale University and an M.B.A. degree from the Stanford University Graduate School of Business.
Lori M. Robson
Class II Director (2006) Audit Committee Governance and Nominating Committee
Dr. Robson has served on the company's board since 1999. Most recently, she was a venture partner of Bay City Capital LLC, a private merchant bank focused on the life science industry. Previously, she was manager of licensing and technology acquisition in the Biotechnology Division of Bayer Corporation, a research-based healthcare, life science and chemical company. She currently serves on the board of Senomyx, Inc., a biotechnology company. Dr. Robson holds a Ph.D. degree in Bacteriology from the University of Wisconsin at Madison and was a post-doctoral fellow at The Johns Hopkins University School of Medicine. She also holds an M.B.A. degree from the University of California, Berkeley, Haas School of Business.
Gregory T. Schiffman
Class II Director (2006) Audit Committee
Gregory T. Schiffman has served as a member of the Board of Directors since April 2006. Since December 2006, Mr. Schiffman has served as Senior Vice President, Chief Financial Officer and Treasurer of Dendreon, Inc., a biopharmaceutical company. From February 2005 to December 2006, Mr. Schiffman served as Executive Vice President and Chief Financial Officer of Affymetrix, Inc., a genetic technology company. Mr. Schiffman held various other positions with Affymetrix since March 2001, including Vice President, Finance, Vice President and Chief Financial Officer and Senior Vice President. Prior to joining Affymetrix, Mr. Schiffman was the Vice President, Controller of Applied Biosystems, Inc., a life sciences company, from October 1998. From 1987 through 1998, Mr. Schiffman held various managerial and financial positions at Hewlett Packard Company, a technology company. Mr. Schiffman currently serves as a director and chairs the audit committee of Entelos, Inc., a publicly traded biopharmaceutical company, and of Nanomix, Inc., a privately-held nanotechnology company. Mr. Schiffman holds a B.S. in Accounting from De Paul University and an M.B.A. from Northwestern University, J. L. Kellogg Graduate School of Management.
Edward W. Unkart
Class I Director (2008) Audit Committee (Chair)
Mr. Unkart has served on the company's board since the completion of its initial public offering in 2004. He is the vice president of Finance and Administration, chief financial officer and assistant secretary of SurgRx, Inc., a company that designs and develops smart electrode technology. From 2001 to 2004, he served as vice president of Finance and Administration, chief financial officer and assistant secretary of Novacept, Inc., a company that designs, develops and sells medical devices for women's healthcare, which was acquired by Cytyc Corporation. From 1999 to 2001, he was vice president of Finance and Administration, chief financial officer and secretary of Praxon, Inc., a manufacturer of small business telephone systems. From 1995 to 1998, he was vice president of Finance and Administration, chief financial officer and assistant secretary of FemRx, Inc., a publicly held women's healthcare company that was acquired by Johnson & Johnson. Mr. Unkart is a certified public accountant and holds both a B.S. degree in Statistics and an M.B.A. degree from Stanford University.
show all
hide all
